Importantly, the Kaplan–Meier survival analysis revealed that the increase in RNF138 expression closely correlates with enhanced disease-free survival (DFS) and improved overall survival (OS) prognoses of patients (Fig. 1g–i), suggesting RNF138 expression level as a prognosis indicator of CRC. This evidence concerns the gene RNF138 and colorectal carcinoma.